A Multicenter, Double-Blind, Placedbo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG0002) on reducing Infarct volume in Acute Ischemic Stroke.
Clinical Trial Grant
Administered By
Neurology, Neurocritical Care
Awarded By
Biogen Idec Inc.
Start Date
November 1, 2013
End Date
May 31, 2015
Administered By
Neurology, Neurocritical Care
Awarded By
Biogen Idec Inc.
Start Date
November 1, 2013
End Date
May 31, 2015